The Claim
In adults with schizophrenia and metabolic syndrome taking antipsychotics, adjunctive berberine at 600 mg/day for 12 weeks reduces net weight gain by 1.08 kg compared to placebo, with a medium effect size (d=0.59), indicating a clinically relevant attenuation of antipsychotic-induced weight gain.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with schizophrenia and metabolic syndrome who are taking antipsychotic medications, taking berberine at 600 mg per day for 12 weeks results in 1.08 kg less weight gain than taking a placebo, with a moderate effect size.
See the scientific wording
In adults with schizophrenia and metabolic syndrome taking antipsychotics, adjunctive berberine (600 mg/day for 12 weeks) reduces net weight gain by 1.08 kg compared to placebo, with a medium effect size (d=0.59), indicating a clinically relevant attenuation of antipsychotic-induced weight gain.
Berberine triggers a cellular energy sensor called AMPK, which turns off fat-making processes in the liver and fat cells, while turning on glucose uptake in muscles. This reduces fat storage and lowers blood sugar, leading to less weight gain.
What the research says
1 studyFor people with schizophrenia who gain weight from their medication, taking 600 mg of berberine daily for 12 weeks helped them gain about 1 kg less than those taking a placebo, without making their psychosis worse.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.